PRLD
Prelude Therapeutics Incorporated
$1.59
+$0.02(+1.27%)
63
Overall
60
Value
66
Tech
--
Quality
Market Cap
$87.16M
Volume
111.38K
52W Range
$0.61 - $1.91
Target Price
$3.50
Key Metrics Overview
| Market Cap | $87.16M | P/E Ratio | N/A |
| 52W High | $1.91 | 52W Low | $0.61 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 11.6% | 52W Position | 75.4% |
| Overall Score | 63 | Value Score | 60 |
| Quality Score | -- | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $-1.51 | EPS Next Est | $-1.24 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $1.59 | +1.3% | 111.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW